Nanologica AB (publ) financials
Nanologica AB (publ)
54930017L41C7P87LP22 | Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | SEK 14.5M | SEK 1.4M |
| Other income | SEK 633.0K | SEK 494.0K |
| Operating expenses | SEK 92.6M | SEK 77.2M |
| Employee benefits expense | SEK 21.6M | SEK 27.4M |
| Raw materials & consumables used | SEK 28.4M | SEK 6.8M |
| Depreciation & amortisation | SEK 15.5M | SEK 19.4M |
| Operating profit (EBIT) | -SEK 59.3M | -SEK 70.0M |
| Net finance income / (cost) | -SEK 6.3M | -SEK 5.2M |
| Finance costs | SEK 6.7M | SEK 5.7M |
| Profit before tax | -SEK 65.6M | -SEK 75.2M |
| Income tax expense | SEK 35.0K | SEK 0 |
| — attributable to owners | -SEK 65.6M | -SEK 75.2M |
| Per share | ||
| Basic EPS | SEK -1.32 | SEK -2.08 |
| Diluted EPS | SEK -1.32 | SEK -2.08 |
| Free cash flow / share | SEK -1.63 | SEK -1.04 |
| Cash flow statement | ||
| Net cash from operating activities | -SEK 80.7M | -SEK 35.8M |
| Net cash from investing activities | -SEK 742.0K | -SEK 20.4M |
| Purchase of PP&E (capex) | SEK 262.0K | SEK 1.8M |
| Purchase of intangibles | SEK 480.0K | SEK 19.2M |
| Net cash from financing activities | SEK 120.2M | -SEK 4.1M |
| Proceeds from borrowings | SEK 15.0M | SEK 0 |
| Repayments of borrowings | SEK 12.0M | SEK 1.3M |
| Lease liability payments | SEK 2.2M | SEK 2.9M |
| Net change in cash | SEK 38.8M | -SEK 60.3M |
| Balance sheet | ||
| Total assets | SEK 143.1M | SEK 77.4M |
| Non-current assets | SEK 29.6M | SEK 38.9M |
| Right-of-use assets | SEK 11.2M | SEK 12.0M |
| Current assets | SEK 113.5M | SEK 38.5M |
| Inventories | SEK 32.7M | SEK 3.0M |
| Trade & other receivables | SEK 896.0K | SEK 473.0K |
| Cash & equivalents | SEK 48.4M | SEK 10.1M |
| Total equity | SEK 74.1M | -SEK 1.9M |
| — attributable to owners | SEK 74.1M | -SEK 1.9M |
| Non-current liabilities | SEK 282.0K | SEK 67.5M |
| Lease liabilities (non-current) | SEK 258.0K | SEK 136.0K |
| Current liabilities | SEK 68.7M | SEK 11.9M |
| Lease liabilities (current) | SEK 2.9M | SEK 530.0K |
| Trade & other payables | SEK 13.1M | SEK 4.9M |
| Derived metrics | ||
| Free cash flow | -SEK 81.0M | -SEK 37.6M |
| Operating margin | -407.6% | -4848.4% |
| Net margin | -451.4% | -5208.4% |
| Return on equity | -88.6% | 3959.8% |
| Cash conversion ratio | 1.23× | 0.48× |
| Capex coverage | -308.14× | -20.41× |
| Other reported items | ||
| Additional Paidin Capital | SEK 442.2M | SEK 308.3M |
| Adjustments For Decrease Increase In Inventories | -SEK 29.8M | -SEK 1.8M |
| Adjustments For Decrease Increase In Other Operating Receivables | -SEK 12.4M | SEK 8.7M |
| Adjustments For Depreciation and Amortisation Expense | SEK 15.4M | SEK 19.0M |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | SEK 9.0M | SEK 9.8M |
| Adjustments For Increase Decrease In Other Operating Payables | SEK 2.8M | SEK 2.2M |
| Adjustments For Provisions | -SEK 583.0K | SEK 0 |
| Cash Flows From Used In Operations Before Changes In Working Capital | -SEK 41.4M | -SEK 45.0M |
| Changes In Inventories of Finished Goods and Work In Progress | -SEK 18.2M | -SEK 2.1M |
| Comprehensive Income Attributable To Owners of Parent | -SEK 65.6M | -SEK 75.2M |
| Copyrights Patents and Other Industrial Property Rights Service and Operating Rights | SEK 0 | SEK 1.3M |
| Current Accrued Expenses and Other Current Liabilities | SEK 4.0M | SEK 4.9M |
| Current Advances To Suppliers | SEK 30.9M | SEK 24.4M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | SEK 376.0K | SEK 18.0K |
| Equity and Liabilities | SEK 143.1M | SEK 77.4M |
| Finance Income | SEK 354.0K | SEK 516.0K |
| Impairment Loss Recognised In Profit Or Loss Intangible Assets Other Than Goodwill | SEK 1.4M | — |
| Impairment Loss Recognised In Profit Or Loss Loans and Advances | SEK 9.0M | SEK 9.8M |
| Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | SEK 9.0M | — |
| Intangible Assets Under Development | SEK 15.2M | SEK 21.8M |
| Interest Paid Classified As Operating Activities | SEK 6.3M | SEK 4.2M |
| Interest Received Classified As Operating Activities | SEK 354.0K | SEK 464.0K |
| Issued Capital | SEK 8.8M | SEK 14.8M |
| Liabilities | SEK 69.0M | SEK 79.3M |
| Miscellaneous Other Operating Expense | SEK 1.5M | SEK 727.0K |
| Noncurrent Portion of Noncurrent Loans Received | SEK 24.0K | SEK 66.8M |
| Number of Shares Outstanding | 88.4M | 36.1M |
| Other Comprehensive Income Attributable To Owners of Parent | SEK 0 | SEK 0 |
| Other Current Financial Liabilities | SEK 47.8M | SEK 0 |
| Other Current Nonfinancial Liabilities | SEK 956.0K | SEK 1.5M |
| Other Current Receivables | SEK 500.0K | SEK 660.0K |
| Other Expense By Nature | SEK 17.1M | SEK 13.1M |
| Other Longterm Provisions | SEK 0 | SEK 572.0K |
| Other Property Plant and Equipment | SEK 3.2M | SEK 3.7M |
| Other Reversals of Provisions | SEK 592.0K | SEK 0 |
| Other Work Performed By Entity and Capitalised | SEK 0 | SEK 3.2M |
| Payments For Share Issue Costs | SEK 12.0M | SEK 0 |
| Payments of Other Equity Instruments | SEK 6.0K | SEK 0 |
| Proceeds From Disposals of Property Plant and Equipment Intangible Assets Other Than Goodwill Investment Property and Other Noncurrent Assets | SEK 0 | SEK 627.0K |
| Proceeds From Exercise of Warrants | SEK 0 | SEK 100.0K |
| Proceeds From Issuing Shares | SEK 131.5M | SEK 0 |
| Retained Earnings | -SEK 376.9M | -SEK 325.0M |
| Weighted Average Shares | 49.5M | 36.1M |
Every line item above is a fact tagged in Nanologica AB (publ)'s annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (SEK), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.